Allen S. Melemed - Jan 18, 2022 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role
Chief Medical Officer
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 05:58 PM
Next filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +240K $0.00 240K Jan 18, 2022 Common Stock 240K $5.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.